Through analyzing the DMs between LPS vs. control group and LPS vs. FGF19 + LPS group, 25 DMs were screened and potentially involved in the protective roles of FGF19 in LPS-induced metabolic disorders. This evidence concerns the gene FGF19 and Other metabolic disease.